COMP <GO>
IBP vs ECG // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Installed Building Products Inc. (NYSE) VS. Everus Construction Group Inc. (NYSE) • 15-METRIC TALLY: IBP 8
— ECG 5
■ METRIC PARITY
LAST: $220.44 (+3.32%) • MKT CAP: $5.67B
options-implied-move
—
LAST: $102.99 (+0.35%) • MKT CAP: $5.24B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IBP VS. ECG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IBP | ECG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 34.00% | 12.10% | +21.90 | IBP | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.70% | 30.40% | -5.70 | ECG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.8x | 13.7x | +0.10 | ECG | /valuation <GO> |
| Free Cash Flow Yield | 5.33% | -0.21% | +5.54 | IBP | /fcf-yield <GO> |
| Operating Margin | 13.00% | 7.10% | +5.90 | IBP | /operating-margins <GO> |
| Net Profit Margin | 8.90% | 5.40% | +3.50 | IBP | /net-margins <GO> |
| Revenue Growth (YoY) | 1.00% | 31.50% | -30.50 | ECG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.55% | 0.00% | +1.55 | IBP | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.66 | 6.47 | -0.81 | ECG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.9 | 41.7 | +20.20 | IBP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 1.13 | -0.08 | ECG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.8x | 22.9x | -3.10 | IBP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.67B | $5.24B | $430.0M | IBP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IBP REV | ECG REV | IBP GROSS % | ECG GROSS % | IBP FCF | ECG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.97B | $3.75B | 34.0% | 12.1% | $300.8M | -$11.7M |
| FY 2024 | $2.94B | $2.85B | 33.8% | 11.9% | $251.4M | $35.1M |
| FY 2023 | $2.78B | $2.85B | — | — | $215.2M | $42.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IBP // BETA 1.05
ECG // BETA 1.13